CBP-307
| CAS No. | CBP-307 | Cat. No. | BCP20840 |
| Name | CBP-307 | ||
| Synonyms | CBP 307; CBP307; | ||
| Formula | C24H26FN3O3 | M. Wt | 423.49 |
| Description | CBP-307 is a novel and selective second generation S1P1 (a G-protein coupled receptor -GPCR) modulator for the treatment of a range of autoimmune disorders, including multiple sclerosis, inflammatory bowel disease and psoriasis. CBP-307 exhibited excellent safety features and potent T cell modulation activity as well as optimal pharmacokinetics and pharmacodynamics profiles, demonstrating the best-in-class potential. CBP-307 is in phase I clinical trials by Suzhou Connect for the treatment of autoimmune diseases. | ||
| Pathways | GPCR/G Protein | ||
| Targets | S1P Receptor | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.